Doug Bevan

Doug Bevan is an experienced professional in pharmaceutical program leadership, currently leading two oncology programs at Deciphera Pharmaceuticals since May 2023, achieving two successful IND submissions. Prior to this, Doug served as Global Program Team Director at EQRx, overseeing the inflammation and immunology portfolio and supporting early clinical development. Doug's tenure at Novartis included roles as Global Program Associate Director, Project Manager for Respiratory Disease, and Scientist 1, contributing to significant projects such as the global Xolair development collaboration and a COVID-19 phase 3 clinical development program. Doug began a career in drug discovery at Cubist Pharmaceuticals and served as a Teaching Assistant at the University of Colorado Boulder. Doug holds a Master's in Organic Chemistry and a Bachelor's in Biochemistry from the University of Colorado Boulder.